LISLE, IL, Oct. 4, 2011 /PRNewswire/ – SXC Health Solutions Corp. (“SXC” or the
“Company”) (NASDAQ: SXCI, TSX: SXC), announced today the completion of
its previously disclosed acquisition of PTRx, Inc. (“PTRx”), a
full-service pharmacy benefit manager (PBM), and SaveDirectRx, Inc.
(“SaveDirectRx”), its exclusive mail-order pharmacy provider, for a
purchase price of $77 million in cash, with an additional $4.5 million
subject to the achievement of certain performance targets through 2012.
The purchase price was paid from SXC’s cash on hand.

“We are excited to close another successful acquisition of a
middle-market PBM operating on our platform,” said Mark Thierer,
Chairman and CEO of SXC. “This acquisition brings additional value and
cost savings opportunities to our clients and a strong team to SXC.”

Both PTRx and SaveDirect are based in San Antonio, where their
operations will remain.

About PTRX, Inc. and SaveDirectRx, Inc.

PTRX is a full-service pharmacy benefit manager with proven success
driving down pharmacy costs for clients and members. PTRX has a
sophisticated, data-driven approach to designing, implementing, and
managing prescription drug plans. Utilizing a benefit plan designed to
drive cost savings, PTRX has become a valuable partner to employers and
third-party administrators (TPA). PTRX employs SaveDirectRx’s
mail-order capabilities to drive cost savings by optimizing the most
cost-efficient drug delivery channel. SaveDirectRx is a fully licensed
mail-order pharmacy with a concentration in the southern United States.
For more information, please visit www.ptrx.com and
www.savedirectrx.com.

About SXC Health Solutions Corp.

SXC Health Solutions Corp. is a leading provider of pharmacy benefits
management (PBM) services and Health Care Information Technology (HCIT)
solutions to the healthcare benefits management industry. The SXC’s
product offerings and solutions combine a wide range of PBM services
and software applications, application service provider (ASP)
processing services and professional services, designed for many of the
largest organizations in the pharmaceutical supply chain, such as
health plans, employers, Federal, provincial, and, state and local
governments, pharmacy benefit managers, retail pharmacy chains and
other healthcare intermediaries. SXC is headquartered in Lisle,
Illinois with multiple locations in the US and Canada. For more
information please visit www.sxc.com.

Forward-Looking Statements

Certain statements included herein, including those that express
management’s expectations or estimates of our future performance,
constitute “forward-looking statements” within the meaning of
applicable securities laws. Forward-looking statements are necessarily
based upon a number of estimates and assumptions that, while considered
reasonable by management at this time, are inherently subject to
significant business, economic and competitive uncertainties and
contingencies. We caution that such forward-looking statements involve
known and unknown risks, uncertainties and other risks that may cause
our actual financial results, performance, or achievements to be
materially different from our estimated future results, performance or
achievements expressed or implied by those forward-looking statements.
Numerous factors could cause actual results to differ materially from
those in the forward-looking statements, including without limitation,
our ability to achieve increased market acceptance for our product
offerings and penetrate new markets; consolidation in the healthcare
industry; the existence of undetected errors or similar problems in our
software products; our ability to identify and complete acquisitions,
manage our growth and integrate acquisitions; our ability to compete
successfully; potential liability for the use of incorrect or
incomplete data; the length of the sales cycle for our healthcare
software solutions; interruption of our operations due to outside
sources; our dependence on, and ability to retain, key customers;
maintaining our intellectual property rights and litigation involving
intellectual property rights; our ability to obtain, use or
successfully integrate third-party licensed technology; compliance with
existing laws, regulations and industry initiatives and future change
in laws or regulations in the healthcare industry; breach of our
security by third parties; our dependence on the expertise of our key
personnel; our access to sufficient capital to fund our future
requirements; and potential write-offs of goodwill or other intangible
assets. This list is not exhaustive of the factors that may affect any
of our forward-looking statements. Other factors that should be
considered are discussed from time to time in SXC’s filings with the
U.S. Securities and Exchange Commission, including the risks and
uncertainties discussed under the captions “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and
Results of Operations” in our 2010 Annual Report on Form 10-K and
subsequent Form 10-Qs, which are available at www.sec.gov. Investors
are cautioned not to put undue reliance on forward-looking statements.
All subsequent written and oral forward-looking statements attributable
to SXC or persons acting on our behalf are expressly qualified in their
entirety by this notice. We disclaim any intent or obligation to update
publicly these forward-looking statements, whether as a result of new
information, future events or otherwise.

SOURCE SXC Health Solutions Corp.